Xidian Pharmaceutical shareholders Guotou Gaokai and Hangzhou Chuanghe plan to collectively reduce their shareholding by no more than 3%; Tangde Film shareholders Dongyang Juwen plan to reduce their shareholding by no more than 2%; Hualv Biotech shareholders Gaotou Development plan to reduce their shareholding by no more than 5.36%; Haoyuan Medicine shareholders Suxin Fund and Zhenjin Investment plan to collectively reduce their shareholding by no more than 3.34%; Tiamaes Technology incurred a net loss of 52.8719 million yuan in the first three quarters; Guandian Defense stocks may be subject to other risk warnings; China Design Group stated that director Liu Peng received a notice of case filing